Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial

Introduction. The prognosis of advanced urological cancers (AUC) remains unfavorable, and few data are available regarding precision medicine. Methods: the PERMED-01 prospective clinical trial assessed the impact of molecular profiling in adults with refractory advanced solid cancer, in terms of num...

Full description

Bibliographic Details
Main Authors: Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle, Jeanne Thomassin-Piana, Géraldine Pignot, Jochen Walz, Christian Chabannon, Jihane Pakradouni, Renaud Sabatier, Cécile Vicier, Cornel Popovici, Emilie Mamessier, Anthony Gonçalves, Daniel Birnbaum, Max Chaffanet, François Bertucci
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
advanced urological cancers
mutation
PERMED-01 trial
precision medicine
sequencing
array-CGH
Online Access:https://www.mdpi.com/2072-6694/14/9/2275

Internet

https://www.mdpi.com/2072-6694/14/9/2275

Similar Items